top of page

Resources

This page includes resources related to my services. Check back later for more content!

Semaglutide

Evidence-based journal articles and videos related to all things semaglutide. 

NEJM
January 2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes

Continued studies showed that participants lost, on average, 15.8% of their body weight, with once weekly semaglutide versus once daily liraglutide. 

 

Read the abstract online here: The New England Journal of Medicine 

NEJM
March 2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Trials showed that participants lost, on average, 14.9% of their body weight, with once weekly semaglutide compared to placebo group. Participants also had significant decreases in total and visceral fat, waist circumference, and systolic blood pressure. There was significant improvement in physical functioning and cardiometabolic risk factors. 

Read the study online here: The New England Journal of Medicine or get the PDF here

bottom of page